My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
SR0033424_ENG DESIGNED PLAN
Environmental Health - Public
>
EHD Program Facility Records by Street Name
>
A
>
AIRPORT
>
10948
>
4200 – Liquid Waste Program
>
SR0033424_ENG DESIGNED PLAN
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
2/17/2021 5:01:01 PM
Creation date
2/17/2021 4:48:15 PM
Metadata
Fields
Template:
EHD - Public
ProgramCode
4200 – Liquid Waste Program
FileName_PostFix
ENG DESIGNED PLAN
RECORD_ID
SR0033424
PE
4202
STREET_NUMBER
10948
Direction
S
STREET_NAME
AIRPORT
STREET_TYPE
WY
City
MANTECA
Zip
95336
ENTERED_DATE
4/9/2003 12:00:00 AM
SITE_LOCATION
10948 S AIRPORT WY
P_LOCATION
99
P_DISTRICT
003
QC Status
Approved
Scanner
SJGOV\sshih
Tags
EHD - Public
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
189
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
T <br /> AdvanTeY"-RX Treatment Systems Overview, cont <br /> Mode 1: Description and Drawing* <br /> Mode 1 AdvanTexTm-RX Treatment Systems are extremely effective at reducing BOD and TSS in process- <br /> ing tank effluent. They're used in conjunction with either a two-compartment processing tank or with a <br /> two-tank system,where the second tank is used as a recirc/blend tank. The filtrate return line drains to a <br /> recirculating splitter valve in either the secondary chamber or the secondary recirc/blend tank; a portion is <br /> diverted back into the tank for further treatment,and a portion is discharged. <br /> E <br /> Side View of AdvanTexTM-RX Treatment System Made 1. <br /> AdvanTexTI"-RX filtrare returns to recirculating splitter valve(RSV)in secondary recirrlblend <br /> chamber for gravity discharge. <br /> EE'= <br /> i <br /> a� <br /> Top Yew of AdvanTexTM-RX Treatment System Mode 1. <br /> `Covered by one or more of the following U.S.patent number;:5,980,748;5,531,894:5.480,561;5,492,635:4,439,323;and 5.360,556. ETP-RX-1 <br /> Additional patents pending. Rev.SA Q N27/011 <br /> Pepe 3 <br />
The URL can be used to link to this page
Your browser does not support the video tag.